{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T19:49:58Z","timestamp":1788896998473,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T00:00:00Z","timestamp":1656288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T00:00:00Z","timestamp":1656288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In Burkina Faso, malaria remains the first cause of medical consultation and hospitalization in health centres. First-line case management of malaria in the country\u2019s health facilities is based on the use of artemisinin-based combination therapy (ACT). To optimize the use of these anti-malarial drugs in the perspective of mitigating the emergence of artemisinin resistance, which is a serious threat to malaria control and elimination, a pilot programme using multiple first-line therapies (MFTs) [three artemisinin-based combinations\u2014pyronaridine\u2013artesunate, dihydroartemisinin\u2013piperaquine and artemether-lumefantrine] has been designed for implementation. As the success of this MFT pilot programme depends on the perceptions of key stakeholders in the health system and community members, the study aimed to assess their perceptions on the implementation of this strategy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Semi-structured interviews, including 27 individual in-depth interviews and 41 focus groups discussions, were conducted with key stakeholders including malaria control policymakers and implementers, health system managers, health workers and community members. Volunteers from targets stakeholder groups were randomly selected. All interviews were recorded, transcribed and translated. Content analysis was performed using the qualitative software programme QDA Miner.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The interviews revealed a positive perception of stakeholders on the implementation of the planned MFT programme. They saw the strategy as an opportunity to strengthen the supply of anti-malarial drugs and improve the management of fever and malaria. However, due to lack of experience with the products, health workers and care givers expressed some reservations about the effectiveness and side-effect profiles of the two anti-malarial drugs included as first-line therapy in the MFT programme (pyronaridine\u2013artesunate, dihydroartemisinin\u2013piperaquine). Questions were raised about the appropriateness of segmenting the population into three groups and assigning a specific drug to each group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The adherence of both populations and key stakeholders to the MFT implementation strategy will likely depend on the efficacy of the proposed drugs, the absence of, or low frequency of, side-effects, the cost of drugs and availability of the different combinations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12936-022-04225-3","type":"journal-article","created":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T04:05:18Z","timestamp":1656302718000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Stakeholder perceptions on the deployment of multiple first-line therapies for uncomplicated malaria: a qualitative study in the health district of Kaya, Burkina Faso"],"prefix":"10.1186","volume":"21","author":[{"given":"Denise","family":"Hien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Moise Tanga","family":"Kabor\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamadou","family":"Siribi\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issiaka","family":"Soulama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nouhoun","family":"Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adama","family":"Baguiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred Bewendtaor\u00e9","family":"Tiono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9-Marie","family":"Tchouatieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sodiomon Bienvenu","family":"Sirima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,27]]},"reference":[{"key":"4225_CR1","unstructured":"WHO. World malaria report 2020. Geneva; World Health Organization. https:\/\/www.who.int\/publications-detail-redirect\/9789240015791. Accessed 24 Aug 2021."},{"key":"4225_CR2","unstructured":"U.S. President\u2019s Malaria Initiative. Burkina Faso Malaria Operational Plan FY. 2022."},{"key":"4225_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3185\/pathexo3235","volume":"102","author":"A Gansan\u00e9","year":"1990","unstructured":"Gansan\u00e9 A, N\u00e9bi\u00e9 I, Soulama I, Tiono A, Diarra A, Konat\u00e9 AT, Ou\u00e9draogo A, Sirima BS. Change of antimalarial first-line treatment in Burkina Faso in 2005 (in French). Bull Soc Pathol Exot. 1990;102:31\u20135.","journal-title":"Bull Soc Pathol Exot"},{"key":"4225_CR4","doi-asserted-by":"publisher","first-page":"68","DOI":"10.11604\/pamj.2020.35.68.20849","volume":"35","author":"I Zongo","year":"2020","unstructured":"Zongo I, Compaor\u00e9 YD, Niki\u00e9ma F, Zongo M, Barry N, Som\u00e9 FA, et al. Efficacy of artemether\u2013lumefantrine and artesunate-amodiaquine as first line therapy of uncomplicated malaria in Burkina Faso, 11 years after policy change. Pan Afr Med J. 2020;35:68.","journal-title":"Pan Afr Med J"},{"key":"4225_CR5","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.4269\/ajtmh.19-0954","volume":"102","author":"MJ Olivera","year":"2020","unstructured":"Olivera MJ, Guerra AP, Cortes LJ, Horth RZ, Padilla J, Novoa J, et al. Artemether\u2013lumefantrine efficacy for the treatment of uncomplicated Plasmodium falciparum infection in Choco, Colombia after 8 years as first-line treatment. Am J Trop Med Hyg. 2020;102:1056\u201363.","journal-title":"Am J Trop Med Hyg"},{"key":"4225_CR6","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s13149-015-0420-y","volume":"108","author":"M Siribi\u00e9","year":"2015","unstructured":"Siribi\u00e9 M, Diarra A, Tiono AB, Soulama I, Sirima SB. Effect of a large scale community-based distribution of artemether\u2013lumefantrine on its therapeutic efficacy among children living in a rural area of Burkina Faso (in French). Bull Soc Pathol Exot. 2015;108:120\u20133.","journal-title":"Bull Soc Pathol Exot"},{"key":"4225_CR7","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12936-018-2440-0","volume":"17","author":"O Raobela","year":"2018","unstructured":"Raobela O, Andriantsoanirina V, Rajaonera DG, Rakotomanga TA, Rabearimanana S, Ralinoro F, et al. Efficacy of artesunate-amodiaquine in the treatment of falciparum uncomplicated malaria in Madagascar. Malar J. 2018;17:284.","journal-title":"Malar J"},{"key":"4225_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12936-019-3089-z","volume":"19","author":"M Lingani","year":"2020","unstructured":"Lingani M, Bonkian LN, Yerbanga I, Kazienga A, Val\u00e9a I, Sorgho H, et al. In vivo\/ex vivo efficacy of artemether\u2013lumefantrine and artesunate\u2013amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso. Malar J. 2020;19:8.","journal-title":"Malar J"},{"key":"4225_CR9","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1086\/522985","volume":"45","author":"I Zongo","year":"2007","unstructured":"Zongo I, Dorsey G, Rouamba N, Dokomajilar C, S\u00e9r\u00e9 Y, Rosenthal PJ, et al. Randomized comparison of amodiaquine plus sulfadoxine\u2013pyrimethamine, artemether\u2013lumefantrine, and dihydroartemisinin\u2013piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso. Clin Infect Dis. 2007;45:1453\u201361.","journal-title":"Clin Infect Dis"},{"key":"4225_CR10","unstructured":"WHO_CDS_RBM_2001.35.pdf. http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/66952\/WHO_CDS_RBM_2001.35.pdf;jsessionid=551F7F191D0F6A30782B6E4D16062369?sequence=1. Accessed 25 Mar 2022."},{"key":"4225_CR11","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0001-706X(94)90060-4","volume":"56","author":"WH Wernsdorfer","year":"1994","unstructured":"Wernsdorfer WH. Epidemiology of drug resistance in malaria. Acta Trop. 1994;56:143\u201356.","journal-title":"Acta Trop"},{"key":"4225_CR12","unstructured":"Rivi\u00e8re-Honegger A, Cottet M, Morandi B. Conna\u00eetre les perceptions et les repr\u00e9sentations, quels apports pour la gestion des milieux aquatiques\u202f? Vincennes: ONEMA; 2014."},{"key":"4225_CR13","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1177\/1757975913507729","volume":"21","author":"FIK Yaya Bocoum","year":"2014","unstructured":"Yaya Bocoum FIK, Kouanda S, Hinson L, Collymore Y. Perceptions des communaut\u00e9s sur le paludisme et les vaccins\u202f: \u00e9tude qualitative r\u00e9alis\u00e9e dans les districts sanitaires de Kaya et Hound\u00e9, au Burkina Faso. Glob Health Promot. 2014;21:76\u201387.","journal-title":"Glob Health Promot"},{"key":"4225_CR14","doi-asserted-by":"crossref","unstructured":"Kibora L. L\u2019\u00e9tude des perceptions des populations et pratiques de d\u00e9veloppement. Bull APAD. 2012. http:\/\/journals.openedition.org\/apad\/4117. Accessed 20 Jan 2020.","DOI":"10.4000\/apad.4117"},{"key":"4225_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0032900","volume":"7","author":"C Pitt","year":"2012","unstructured":"Pitt C, Diawara H, Ou\u00e9draogo DJ, Diarra S, Kabor\u00e9 H, Kou\u00e9la K, et al. Intermittent preventive treatment of malaria in children: a qualitative study of community perceptions and recommendations in Burkina Faso and Mali. PLoS ONE. 2012;7: e32900.","journal-title":"PLoS ONE"},{"key":"4225_CR16","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/1475-2875-11-185","volume":"11","author":"G Okello","year":"2012","unstructured":"Okello G, Ndegwa SN, Halliday KE, Hanson K, Brooker SJ, Jones C. Local perceptions of intermittent screening and treatment for malaria in school children on the south coast of Kenya. Malar J. 2012;11:185.","journal-title":"Malar J"},{"key":"4225_CR17","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12936-016-1123-y","volume":"15","author":"K Shuford","year":"2016","unstructured":"Shuford K, Were F, Awino N, Samuels A, Ouma P, Kariuki S, et al. Community perceptions of mass screening and treatment for malaria in Siaya County, western Kenya. Malar J. 2016;15:71.","journal-title":"Malar J"},{"key":"4225_CR18","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.4103\/jfmpc.jfmpc_295_18","volume":"8","author":"IP Okafor","year":"2019","unstructured":"Okafor IP, Ezekude C, Oluwole EO, Onigbogi OO. Malaria in pregnancy: A community-based study on the knowledge, perception, and prevention among Nigerian women. J Fam Med Prim Care. 2019;8:1359\u201364.","journal-title":"J Fam Med Prim Care"},{"key":"4225_CR19","first-page":"62","volume":"43","author":"F Rakhshani","year":"2014","unstructured":"Rakhshani F, Ansari-Moghadam A, Mohammadi M, Ranjbar M, Raeisi A, Rakhshani T. Community perceptions and practices about malaria prevention and control in Iran. Iran J Public Health. 2014;43:62\u20139.","journal-title":"Iran J Public Health"},{"key":"4225_CR20","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1186\/s12889-018-5299-7","volume":"18","author":"P Dambach","year":"2018","unstructured":"Dambach P, Jorge MM, Traor\u00e9 I, Phalkey R, Sawadogo H, Zabr\u00e9 P, et al. A qualitative study of community perception and acceptance of biological larviciding for malaria mosquito control in rural Burkina Faso. BMC Public Health. 2018;18:399.","journal-title":"BMC Public Health"},{"key":"4225_CR21","doi-asserted-by":"publisher","first-page":"679","DOI":"10.3917\/spub.145.0679","volume":"26","author":"KM Drabo","year":"2014","unstructured":"Drabo KM, Sawadogo A, Laokri S, Saizonou J, Hien H, Ouedraogo TL. Pratiques de pr\u00e9vention antipaludique dans les zones p\u00e9riurbaines de deux districts sanitaires du Burkina Faso. Sante Publique. 2014;26:679\u201384.","journal-title":"Sante Publique"},{"key":"4225_CR22","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12936-015-0591-9","volume":"14","author":"T Druetz","year":"2015","unstructured":"Druetz T, Ridde V, Kouanda S, Ly A. Utilization of community health workers for malaria treatment: results from a three-year panel study in the districts of Kaya and Zorgho, Burkina Faso. Malar J. 2015;14:71.","journal-title":"Malar J"},{"key":"4225_CR23","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3917\/spub.154.0557","volume":"27","author":"I Sombi\u00e9","year":"2015","unstructured":"Sombi\u00e9 I, Amendah D, Soubeiga KA. Les perceptions locales de la participation communautaire \u00e0 la sant\u00e9 au Burkina Faso. Sante Publique. 2015;27:557\u201364.","journal-title":"Sante Publique"},{"key":"4225_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0180508","volume":"12","author":"S Yaya","year":"2017","unstructured":"Yaya S, Bishwajit G, Ekholuenetale M, Shah V, Kadio B, Udenigwe O. Knowledge of prevention, cause, symptom and practices of malaria among women in Burkina Faso. PLoS ONE. 2017;12: e0180508.","journal-title":"PLoS ONE"},{"key":"4225_CR25","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1186\/1471-2458-10-409","volume":"10","author":"KP Asante","year":"2010","unstructured":"Asante KP, Abokyi L, Zandoh C, Owusu R, Awini E, Sulemana A, et al. Community perceptions of malaria and malaria treatment behaviour in a rural district of Ghana: implications for artemisinin combination therapy. BMC Public Health. 2010;10:409.","journal-title":"BMC Public Health"},{"key":"4225_CR26","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1046\/j.1365-3156.1999.00471.x","volume":"4","author":"HA Williams","year":"1999","unstructured":"Williams HA, Kachur SP, Nalwamba NC, Hightower A, Simoonga C, Mphande PC. A community perspective on the efficacy of malaria treatment options for children in Lundazi District, Zambia. Trop Med Int Health. 1999;4:641\u201352.","journal-title":"Trop Med Int Health"},{"key":"4225_CR27","doi-asserted-by":"publisher","first-page":"140","DOI":"10.4314\/mmj.v30i3","volume":"30","author":"CH Coelho","year":"2018","unstructured":"Coelho CH. Malaria vaccines as prevention strategies: for more studies on community perception. Malawi Med J. 2018;30:140.","journal-title":"Malawi Med J"},{"key":"4225_CR28","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1186\/1471-2458-13-312","volume":"13","author":"A Abate","year":"2013","unstructured":"Abate A, Degarege A, Erko B. Community knowledge, attitude and practice about malaria in a low endemic setting of Shewa Robit Town, northeastern Ethiopia. BMC Public Health. 2013;13:312.","journal-title":"BMC Public Health"},{"key":"4225_CR29","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12936-017-1798-8","volume":"16","author":"I Mitiku","year":"2017","unstructured":"Mitiku I, Assefa A. Caregivers\u2019 perception of malaria and treatment-seeking behaviour for under five children in Mandura District, West Ethiopia: a cross-sectional study. Malar J. 2017;16:144.","journal-title":"Malar J"},{"key":"4225_CR30","unstructured":"Minist\u00e8re de la sant\u00e9. annuaire_ms_2018.pdf. 2020 Disponible sur: http:\/\/cns.bf\/IMG\/pdf\/annuaire_ms_2018.pdf. Accessed 7 Feb 2020."},{"key":"4225_CR31","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-040220","volume":"11","author":"M Siribi\u00e9","year":"2021","unstructured":"Siribi\u00e9 M, Tchouatieu AM, Soulama I, Kabor\u00e9 JMT, Nombr\u00e9 Y, Hien D, et al. Protocol for a quasi-experimental study to assess the feasibility, acceptability and costs of multiple first-lines artemisinin-based combination therapies for uncomplicated malaria in the Kaya health district, Burkina Faso. BMJ Open. 2021;11: e040220.","journal-title":"BMJ Open"},{"key":"4225_CR32","doi-asserted-by":"publisher","first-page":"228","DOI":"10.4314\/ijbcs.v11i1.18","volume":"11","author":"FH Yanda\u00ef","year":"2017","unstructured":"Yanda\u00ef FH, Moundine K, Djoumbe E, Boulotigam K, Moukenet A, Kodindo ID, et al. Perception de risques du paludisme et utilisation des moustiquaires au Tchad. Int J Biol Chem Sci. 2017;11:228.","journal-title":"Int J Biol Chem Sci"},{"key":"4225_CR33","first-page":"243","volume-title":"Soci\u00e9t\u00e9s, d\u00e9veloppement et sant\u00e9","author":"D Bonnet","year":"1990","unstructured":"Bonnet D. Anthropologie et sant\u00e9 publique: une approche du paludisme au Burkina Faso. In: Fassin D, Jaffre Y, editors. Soci\u00e9t\u00e9s, d\u00e9veloppement et sant\u00e9. Paris: Ellipses (Universit\u00e9s francophones); 1990. p. 243\u201358."},{"key":"4225_CR34","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12936-018-2200-1","volume":"17","author":"F Grandesso","year":"2018","unstructured":"Grandesso F, Guindo O, Woi Messe L, Makarimi R, Traore A, Dama S, et al. Efficacy of artesunate-amodiaquine, dihydroartemisinin-piperaquine and artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Maradi, Niger. Malar J. 2018;17:52.","journal-title":"Malar J"},{"key":"4225_CR35","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1016\/S0140-6736(18)30291-5","volume":"391","author":"I Sagara","year":"2018","unstructured":"Sagara I, Beavogui AH, Zongo I, Soulama I, Borghini-Fuhrer I, Fofana B, et al. Pyronaridine\u2013artesunate or dihydroartemisinin\u2013piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b\/4 trial. Lancet. 2018;391:1378\u201390.","journal-title":"Lancet"},{"key":"4225_CR36","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3917\/spub.124.0365","volume":"24","author":"H Saouadogo","year":"2012","unstructured":"Saouadogo H, Amoussou KM, Ou\u00e9draogo L. \u00c9tude des m\u00e9canismes p\u00e9rennes de financement des m\u00e9dicaments essentiels \u00e0 Loumbila, Burkina Faso. Sante Publique. 2012;24:365\u201377.","journal-title":"Sante Publique"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-022-04225-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-022-04225-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-022-04225-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T04:22:43Z","timestamp":1656303763000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-022-04225-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,27]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["4225"],"URL":"https:\/\/doi.org\/10.1186\/s12936-022-04225-3","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,27]]},"assertion":[{"value":"4 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Health Research Ethics Committee in Burkina Faso approved the study (Clearance no. 2018-8-113). All interviewed participants were informed about the study and signed an informed consent form before the interviews began.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"202"}}